MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals
NCT ID: NCT04996316
Last Updated: 2025-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
1141 participants
OBSERVATIONAL
2022-09-07
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Communicating Objective Risk for Personalized Decision Making About Mammography
NCT01686360
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
NCT00255060
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
NCT00462891
Opt-in vs. Opt-out for Breast Cancer Screening
NCT05313737
Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study
NCT05838417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Uptake of MammoScreen (the proportion of women who enroll and use MammoScreen, also referred to as Reach.
II. Identification of women with above-average risk for breast cancer by MammoScreen integrated with the electronic health record (EHR).
SECONDARY OUTCOMES:
I. Rates of mammography screening referral. II. Screening completed and mammography results stratified by risk category. III. Among those who meet criteria, genetic counseling referral, visit completed and genetic test done.
OUTLINE:
CLINICAL STAFF: During development some clinical team members will participate in usability testing (up to 30 minutes) of the electronic health record interface with MammoScreen. Some participants will undergo training sessions of about 20 minutes, then participate in interviews lasting up to 30 minutes at baseline prior to MammoScreen launch. Clinical staff also participate in interviews up to 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the maintenance phase about six months after the last reminders are sent.
PATIENTS: Patients (enrolled from OHSU IMC) participate in interviews lasting up to 1 hour. Patients medical records are reviewed. Patients will be invited via MyChart to use the MammoScreen. Reminders will be sent via MyChart to non-respondents at 2 and 4 weeks. Patients will use MammoScreen one time right after enrollment. Some patients may also participate in interviews up to 1 hour each during years 3-5.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinical staff (interview, training, survey)
Before implementation, some participants will complete usability testing of the interface in the electronic health record and MammoScreen. Participants undergo training sessions over 20 minutes and participate in interviews over 30 minutes at baseline, prior to MammoScreen launch. Clinical staff also participate in interviews over 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the maintenance phase, about six months after the last reminders are sent.
Electronic Health Record Review
Health record reviewed
Interview
Participate in interview
Survey Administration
Complete survey
Training and Education
Undergo training
Patients (interview, MammoScreen)
Patients participate in interviews up to 1 hour. Patients medical records are reviewed. Patients use the MammoScreen at enrollment. Some Patients will also participate in interviews up to 1 hour, each during years 3-5.
Electronic Health Record Review
Health record reviewed
Interview
Participate in interview
Media Intervention
Use MammoScreen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electronic Health Record Review
Health record reviewed
Interview
Participate in interview
Media Intervention
Use MammoScreen
Survey Administration
Complete survey
Training and Education
Undergo training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Enrolled in MyChart
* Able to read English
Exclusion Criteria
* Currently Pregnant
* Currently in Hospice
40 Years
74 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Oregon Health and Science University
OTHER
OHSU Knight Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Eden, Ph.D.
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Eden, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Medical Informatics and Clinical Epidemiology, OHSU Knight Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OHSU Knight Cancer Institute
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-06583
Identifier Type: REGISTRY
Identifier Source: secondary_id
STUDY00022698
Identifier Type: OTHER
Identifier Source: secondary_id
STUDY00022698
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.